Childhood Medulloepithelioma Completed Phase 1 Trials for Vorinostat (DB02546)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0030159 (Childhood Medulloepithelioma) | Completed | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00994500 | Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma | Treatment | |
| NCT01076530 | Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors | Treatment |